Clough Capital Partners’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $7.62M | Buy |
|
|||||
|
2023
Q1 | $1.84M | Sell |
|
|||||
|
2022
Q4 | $1.48M | Sell |
|
|||||
|
2022
Q3 | $2.91M | Sell |
|
|||||
|
2022
Q2 | $6.44M | Hold |
|
|||||
|
2022
Q1 | $7.24M | Buy |
|
|||||
|
2021
Q4 | $6.23M | Sell |
|
|||||
|
2021
Q3 | $4.54M | Hold |
|
|||||
|
2021
Q2 | $8.71M | Sell |
|
|||||
|
2021
Q1 | $21M | Buy |
|
|||||
|
2020
Q4 | $13.3M | Sell |
|
|||||
|
2020
Q3 | $12.2M | Hold |
|
|||||
|
2020
Q2 | $13.3M | Hold |
|
|||||
|
2020
Q1 | $10.9M | Sell |
|
|||||
|
2019
Q4 | $15.9M | Hold |
|
|||||
|
2019
Q3 | $12.5M | Sell |
|
|||||
|
2019
Q2 | $15M | Buy |
|
|||||
|
2019
Q1 | $11.5M | Buy |
|
|||||
|
2018
Q4 | $7.42M | Sell |
|
|||||
|
2018
Q3 | $10.5M | Buy |
|
|||||
|
2018
Q2 | $12.7M | Sell |
|
|||||
|
2018
Q1 | $13.7M | Sell |
|
|||||
|
2017
Q4 | $19.7M | Buy |
|